QI Grant Program: Biomarker Testing in Metastatic Colorectal Cancer (mCRC)
Improve testing for RAS/KRAS/NRAS, BRAF, HER2, MSI/MMR biomarkers in frontline mCRC treatment selection.
Key Activities
Multi-year QI grant program; up to $250K per project; ASCP administers; focus on optimizing testing practices, care team communication/coordination, scalable lessons. RFP opened January 26, 2026.